| KCA: Small Study Shows 90% Benefit Rate in Papillary Kidney Cancer - MedPage Today |
|
|
MedPage TodayCHICAGO -- Almost all patients with papillary renal carcinoma had stable disease or better response to treatment with a drug that targets multiple growth ... read more |